Logo

Bio-Techne

Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve

Its ProteinSimple proteomic analytical tools and Advanced Cell Diagnostics tissue biopsy products were standouts in the quarter, Bio-Techne's CEO said.

New Products Posted to GenomeWeb: Pacific Biosciences, Paragon Genomics, Bio-Techne, More

In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences

News items for the week of April 5, 2021.

Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test

The firm said it will begin running its urine-based test immediately in its clinical laboratory in Munich and make it available throughout Europe.

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.

Mar 3, 2021

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Mar 1, 2021

Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test

Feb 2, 2021

Bio-Techne Fiscal Q2 Revenues Rise 21 Percent

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Dec 2, 2020

Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

Nov 5, 2020

Bio-Techne Fiscal Q1 Revenues Rise 11 Percent on Diagnostics and Genomics Sales

Sep 17, 2020

Bio-Techne, Qiagen Expand Partnership on Exosome Technology

Aug 24, 2020

Inflammatory Cytokine Biomarkers Predict COVID-19 Survival, Could Yield Dx, Rx Targets

Aug 21, 2020

New Products Posted to GenomeWeb: Thermo Fisher, Qiagen, Bio-Techne, More

Aug 4, 2020

Bio-Techne Q4 Revenues Drop 8 Percent

Jun 12, 2020

In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More

May 26, 2020

Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform

May 20, 2020

Bio-Techne Bets Clinical Utility Study Data Will Sway Payors to Cover Prostate Cancer Risk Test
Premium

Apr 30, 2020

Bio-Techne Fiscal Q3 Revenues Rise 5 Percent Despite Coronavirus Challenges

Mar 18, 2020

Bio-Techne Lands Government Contract for Genomic Prostate Cancer Test

Feb 4, 2020

Bio-Techne FY Q2 Revenues Rise 6 Percent, Miss Analysts' Estimate

Oct 29, 2019

Bio-Techne Fiscal Q1 Revenues Rise 12 Percent

Oct 10, 2019

Bio-Techne Receives Medicare Coverage for Prostate Cancer Test

Aug 6, 2019

Bio-Techne's Fiscal Q4 Revenues Rise 6 Percent; Firm Misses Wall Street Estimates

Jun 13, 2019

Bio-Techne Gets New York State Approval for Prostate Cancer Test

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.